SCHEMBL662073

SCHEMBL662073

COc1cc(-c2[o+]c3cc(O)cc(OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3cc2OC2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc(OC)c1O

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.72
CD38 P28907 2/20 0.64
DPP4 P27487 2/20 0.64
TYR P14679 1/20 0.55
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
SLC28A3 Q9HAS3 2/20 0.47
ACHE P22303 1/20 0.47
POLB P06746 1/20 0.47
MAOA P21397 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA13 Q8N1Q1 1/20 0.46
PTGS1 P23219 1/20 0.45
EPHX2 P34913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6139298 1.00 F2 (0.72) F2CD38DPP4TYRMEN1
SCHEMBL6139200 1.00 F2 (0.72) F2CD38DPP4TYRMEN1
Hydrochloric Acid SCHEMBL316879 0.99 F2 (0.71) F2CD38DPP4TYRMEN1
Hydrochloric Acid SCHEMBL3769735 0.99 F2 (0.71) F2CD38DPP4TYRMEN1
Hydrochloric Acid SCHEMBL316878 0.99 F2 (0.71) F2CD38DPP4TYRMEN1
Hydrochloric Acid SCHEMBL3767542 0.98 F2 (0.70) F2CD38DPP4TYRMEN1
SCHEMBL29532883 0.97 F2 (0.75) F2CD38DPP4TYRMEN1
Hydrochloric Acid SCHEMBL30540085 0.96 F2 (0.73) F2CD38DPP4TYRMEN1
Oenin SCHEMBL676018 0.93 CD38 (0.74) F2CD38DPP4TYRMEN1
Oenin SCHEMBL662772 0.93 CD38 (0.74) F2CD38DPP4TYRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240010998-A1 FLAVONE 4'-O-METHYLTRANSFERASE GENE AND USE FOR SAME SUNTORY HOLDINGS LIMITED (JP) 2024-01-11 US claimed
EP-4249597-A1 FLAVONE 4'-O-METHYLTRANSFERASE GENE AND USE FOR SAME Suntory Holdings Limited (JP) 2023-09-27 EP claimed
WO-2023004029-A1 COMPOSITION FOR PREVENTING TEETH STAINING ONSTAD ANDREW (US) 2023-01-26 WO claimed
WO-2022194862-A1 METHOD FOR PREDICTING THE LIKELIHOOD OF PREGNANCY IN FEMALE MAMMALS WHICH EXPERIENCE AN ESTROUS CYCLE BREEDSENSE AS (NO) 2022-09-22 WO claimed
US-20220279829-A1 Use of Anthocyanin-Anionic Polysaccharide Complex for Preventing or Treating Influenza Virus A Infection JBKLAB CO., LTD. (KR) 2022-09-08 US claimed
US-20220249675-A1 Composition for Preventing, Ameliorating, or Treating Gastritis or peptic Ulcer Comprising Anthocyanin-Negatively Charged Polysaccharide Complex as Active Ingredient JBKLAB CO., LTD. (KR) 2022-08-11 US claimed
US-20220241308-A1 NEURONAL FUNCTION MODULATING AGENT UNIVERSITY OF TSUKUBA (JP) 2022-08-04 US claimed
US-20220233626-A1 GRAPE PERICARP EXTRACT UNIVERSITY OF TSUKUBA (JP) 2022-07-28 US claimed
US-20220175867-A1 GRAPE EXTRACT, METHOD FOR PRODUCING GRAPE EXTRACT LIQUID, METHOD FOR PRODUCING EXTRACTED AND PURIFIED PRODUCT OF GRAPE, AND METHOD FOR PRODUCING DRIED PRODUCT OF EXTRACTED AND PURIFIED PRODUCT OF GRAPE ZEON CORPORATION (JP) 2022-06-09 US claimed
US-20220119461-A1 UNIQUE APHID POLYPEPTIDES FOR USE IN MODIFYING CELLS HOWARD HUGHES MEDICAL INSTITUTE 2022-04-21 US claimed
CN-112717036-A Preparation and application of crocus sativus extract with antioxidant activity and without stigma 中国中医科学院中药研究所 2021-04-30 CN claimed
WO-2020246272-A1 GRAPE SKIN EXTRACT 国立大学法人 筑波大学 2020-12-10 WO claimed
WO-2020246271-A1 NEUROLOGICAL FUNCTION REGULATING AGENT 国立大学法人 筑波大学 2020-12-10 WO claimed
WO-2020203940-A1 FLAVONE 7-O-METHYLTRANSFERASE GENE AND USE FOR SAME サントリーホールディングス株式会社 2020-10-08 WO claimed
US-20200283782-A1 TRANSFORMED PLANT HAVING BLUE FLOWER COLOR, AND METHOD FOR CREATING SAME SUNTORY HOLDINGS LIMITED (JP) 2020-09-10 US claimed
EP-2606144-B1 ESTROUS CYCLE MONITORING BY COLOR RESPONSE ORATEL DIAGNOSTICS LLC (US) 2016-06-15 EP claimed
US-8841130-B2 Methods and kit for endometriosis diagnosis ORATEL DIAGNOSTICS, LLC (US) 2014-09-23 US claimed
EP-2606144-A2 ESTROUS CYCLE MONITORING BY COLOR RESPONSE Oratel Diagnostics, LLC (US) 2013-06-26 EP claimed
WO-2012024095-A2 ESTROUS CYCLE MONITORING BY COLOR RESPONSE ORATEL DIAGNOSTICS, LLC (US) 2012-02-23 WO claimed
WO-2002024212-A1 CHOLESTEROL IN BLOOD-LOWERING COMPOSITION AND ITS COMPLEX, AND METHOD FOR PREPARING THEM ULTIMATE LIFE TECHNOLOGY CO., LTD. (KR) 2002-03-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220241308-A1 NEURONAL FUNCTION MODULATING AGENT GAP43, NLN, GMFG F2 4789/4885CD38 2791/4885DPP4 592/4885
US-20220233626-A1 GRAPE PERICARP EXTRACT GRIK3, GRIK5, GRIK4 F2 4666/4885CD38 1374/4885DPP4 45/4885
US-20220175867-A1 GRAPE EXTRACT, METHOD FOR PRODUCING GRAPE EXTRACT LIQUID, METHOD FOR PRODUCING EXTRACTED AND PURIFIED PRODUCT OF GRAPE, AND METHOD FOR PRODUCING DRIED PRODUCT OF EXTRACTED AND PURIFIED PRODUCT OF GRAPE GMDS, MGAM, ME1 F2 452/4885CD38 970/4885DPP4 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.